Tci Wealth Advisors, Inc. Kaleido Biosciences, Inc. Transaction History

Tci Wealth Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 02, 2021	SELL	$5.82 - $8.72 $1,018 - $1,526	-175 Closed	0 $0
Q1 2021 Apr 29, 2021	SELL	$7.2 - $16.82 $1,864 - $4,356	-259 Reduced 59.68%	175 $1,000
Q4 2020 Jan 21, 2021	BUY	$5.77 - $11.33 $2,504 - $4,917	434 New	434 $4,000
Q3 2020 Oct 20, 2020	SELL	$5.09 - $11.07 $987 - $2,147	-194 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$4.62 - $8.01 $896 - $1,553	194 New	194 $1,000

2.65K

Ticker KLDO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,622,600
Description
Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.